Searched for
NATCO PHARMA PB RATIO
Christy Mathai used market dip to buy insurance, logistics stocks; here's his sector-by-sector playbookFund Manager Christy Mathai sees easing war-driven inflation fears, expecting a shorter earnings hit. He's selectively adding to his portfo...- F&O Radar: Call Ratio Spread strategy for ICICI Bank this weekICICI Bank shows a sustained uptrend with bullish technical indicators including higher highs, strong RSI and a weekly hammer pattern. Anal...
- F&O Radar: Call ratio spread strategy for Bank of Baroda this weekBank of Baroda has broken out of a consolidation range with bullish technical indicators, including a weekly bullish engulfing pattern and ...
- Telecom tower companies eye 5–6% tenancy growth on network pushTelecom tower companies anticipate strong tenancy growth of five to six percent in the coming two fiscal years. This surge is fueled by tel...
- Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...
- JLR sets out path to double-digit revenue growth through greater propulsion flexibility, North America pushJaguar Land Rover is launching a new growth plan. The company will offer more engine choices, including electric and hybrid options, for it...
- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- Retail players can skip GIC Re's OFS: AnalystsRetail investors are advised to skip the government's offer for sale in General Insurance Corp of India. Analysts point to ongoing profitab...
- JLR pivots to flexible powertrains amid slow pace of electrificationJaguar Land Rover is adjusting its strategy. The company will offer a mix of petrol, hybrid, and electric vehicles. This change comes after...
- Quant Mid Cap Fund adds Adani Energy and 4 others, exits Paytm and 3 more stocks in MayQuant Mid Cap Fund, managed by Sandeep Tandon, has strategically adjusted its portfolio in May. The fund added Adani Energy and four other ...
- Two Trades for Today: 2 pharma companies – a large-cap for a 5% rise, and a mid-cap stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Former Paisabazaar CEO Naveen Kukreja eyes $9-million raise for new wealthtech betFormer Paisabazaar CEO Naveen Kukreja is reportedly seeking $9 million for his new wealthtech startup, aiming to build a platform for retai...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- India's current account deficit to remain 1.5-1.7% of GDP in FY27 but RBI measures may turn BoP surplus: SBI ReportIndia's current account deficit is projected for FY27. However, Reserve Bank of India measures are anticipated to improve the country's ext...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- RVNL shares jump 3% after securing Rs 221 crore Railway contractRVNL shares saw an uptick on Tuesday after the company secured a Rs 221.33 crore railway signalling and infrastructure upgrade contract fro...
- Go Digit Insurance shares jump 9% after Rs 100 crore block deal attracts MFs, global investorGo Digit General Insurance shares saw a significant jump. This surge followed a Rs 100-crore block deal. Aditya Birla Sun Life Mutual Fund ...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- PB Fintech shares in focus after founders sell stake worth Rs 665 crore in Policybazaar parentPB Fintech founders sold shares worth Rs 665 crore. Yashish Dahiya and Alok Bansal offloaded stock on Friday. Major investors like Goldman ...
- Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoYNatco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins an...
Load More
